In a series of Budget announcements, the Finance Minister outlined changes spanning taxation, customs duties, and healthcare imports that collectively carry implications for corporate behaviour, consumer access, and sectoral cost structures.

A key tax change relates to the treatment of share buybacks. The clarification that buybacks will be treated as capital gains in the hands of minority shareholders is being viewed as favourable for companies with large cash reserves and a history of returning capital to investors. According to market participants, this is particularly relevant for India’s IT services majors, which often accumulate significant surplus cash on their balance sheets and periodically consider buybacks as a mode of capital return.

By aligning the tax treatment more closely with capital gains, the move could make buybacks a more attractive route compared to dividends from a shareholder perspective, depending on individual tax situations. This, in turn, may influence how companies evaluate future capital allocation decisions, especially in sectors where organic reinvestment opportunities are relatively stable and cash generation remains strong.

In another significant tax change, the Finance Minister announced that the Minimum Alternate Tax will become the final tax with no further MAT credit available from April 1, 2026. Additionally, the MAT rate has been reduced from 15 percent to 14 percent. This signals an attempt to simplify the tax structure while slightly lowering the effective burden for companies that fall under the MAT regime. For companies that have historically accumulated MAT credits, this change may alter the way deferred tax assets are viewed on balance sheets over time.

On the customs side, the Budget includes multiple duty rationalisation measures aimed at reducing costs for specific sectors. The exemption of basic customs duty on parts of microwave ovens is a direct boost to electronics manufacturing, particularly for companies assembling consumer appliances in India. Lower input duties can improve margins for domestic manufacturers or allow for more competitive pricing in the market.

The Finance Minister also proposed reducing the tariff rate on personal goods imports from 20 percent to 10 percent. While this move is broader in scope, it reflects a calibrated approach to tariff rationalisation that may affect consumer goods imports and pricing dynamics across categories.

A notable healthcare-related announcement is the exemption of duty on 17 cancer drugs. This measure is likely aimed at improving affordability and access to critical treatments. For patients and healthcare providers, lower import duties can translate into reduced costs for high-value therapies, particularly where domestic manufacturing capacity is limited.

In addition, the government proposed to exempt basic customs duty on components and parts required for the manufacture of civil training and other aircraft. This signals continued policy support for the domestic aerospace manufacturing ecosystem, particularly in areas linked to training aircraft and allied components. Lower duties on parts can help reduce production costs and encourage localisation of assembly and manufacturing activities.

Taken together, these measures indicate a Budget approach that uses targeted tax and duty changes to influence behaviour across sectors rather than relying solely on direct incentives. The combination of tax clarity on buybacks, MAT rationalisation, and customs exemptions touches corporate finance decisions, manufacturing cost structures, and healthcare affordability simultaneously.

The change in buyback tax treatment is likely to draw attention in the IT services space, where companies with large cash reserves may re-evaluate capital return strategies. Duty exemptions for electronics and aerospace components can be seen as supportive for domestic manufacturing themes, while healthcare exemptions carry social as well as economic implications.

• Technology: Potentially positive due to improved attractiveness of buybacks for shareholders

• Industrials and Consumer Electronics: Benefit from lower input duties on components

• Healthcare: Positive for access and affordability of cancer treatments

• Aerospace Manufacturing: Supportive through lower duty on critical parts